Screener
Opko Health OPK Pharmaceutical — Operating Income
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Opko Health’s 10-Q, filed July 27, 2026.
- Filed
- Jul 27, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-318090
| (In thousands) / Revenue from services: / Pharmaceutical | For the three months ended June 30, 2026 / — | For the three months ended June 30, 2025 / — | For the six months ended June 30, 2026 / — | For the six months ended June 30, 2025 / — |
|---|---|---|---|---|
| Diagnostics | (18,070) | — | (18,070) | — |
| Corporate | — | — | — | — |
| $(18,070) | $— | $(18,070) | $— | |
| Segment operating loss: | ||||
| Pharmaceutical | $839 | $(28,706) | $(28,839) | $(63,470) |
| Diagnostics | 4,756 | (18,164) | (8,196) | (42,082) |
| Corporate | (12,567) | (13,111) | (20,952) | (21,596) |
| $(6,972) | $(59,981) | $(57,987) | $(127,148) |
Item 1. Financial Statements
FAQ
- What is Opko Health's pharmaceutical — operating income?
- Opko Health (OPK) reported pharmaceutical — operating income of $839K in Q2 2026.
- How has Opko Health's pharmaceutical — operating income changed year-over-year?
- Opko Health's pharmaceutical — operating income increased by 102.9% year-over-year, from -$28.71M to $839K.
- What is the long-term trend for Opko Health's pharmaceutical — operating income?
- Over 3 years (2021 to 2025), Opko Health's pharmaceutical — operating income has grown at a 72.8% compound annual growth rate (CAGR), from -$19.05M to -$98.34M.
- What does pharmaceutical — operating income mean?
- The profit or loss generated by the pharmaceutical segment after accounting for all operating revenues and expenses, including production costs, R&D, and administrative overhead. It serves as the primary measure of the segment's operational performance and financial health.
Ask your AI about Opko Health's pharmaceutical — operating income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude